VistaGen Therapeutics, Inc.(VTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTGN VistaGen Therapeutics, Inc.

盘前交易 05-27 07:32:41 EDT

0.6367

-0.0103

-1.59%

最高0.6515	最低0.6352	成交量28.78万
今开0.6500	昨收0.6470	日振幅2.52%
总市值2,515万	流通市值1,958万	总股本3,950万
成交额18.52万	换手率0.94%	流通股本3,075万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics, Inc.","latestPrice":0.6367,"timestamp":1779825600000,"preClose":0.647,"halted":0,"volume":287825,"delay":0,"changeRate":-0.01591962905718698,"floatShares":30750300,"shares":39495451,"eps":-1.900316,"marketStatus":"盘前交易","change":-0.0103,"latestTime":"05-27 07:32:41 EDT","open":0.65,"high":0.6515,"low":0.6352,"amount":185210.4196405,"amplitude":0.025193,"askPrice":0.6648,"askSize":10,"bidPrice":0.61,"bidSize":85,"shortable":3,"etf":0,"ttmEps":-1.900316,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779888600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":0.6367,"postHourTrading":{"tag":"盘后","latestPrice":0.6494,"preClose":0.6367,"latestTime":"19:43 EDT","volume":1583,"amount":1023.2924,"timestamp":1779839035130,"change":0.0127,"changeRate":0.019947,"amplitude":0.019947},"volumeRatio":0.5540775447294437,"impliedVol":4.0035,"impliedVolPercentile":0.9},"requestUrl":"/m/hq/s/VTGN/tweets","defaultTab":"tweets","newsList":[{"id":"1114884667","title":"VistaGen Therapeutics, Inc. 旗下Fasedienol鼻喷雾剂耐受性良好，12个月后无新增安全性发现","url":"https://stock-news.laohu8.com/highlight/detail?id=1114884667","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114884667?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:31","pubTimestamp":1778585476,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics, Inc. 宣布，其Fasedienol鼻喷雾剂在为期12个月的观察期内展现出良好的耐受性，未发现新的安全性问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172520288","title":"Vistagen披露Palisade-3三期研究开放标签扩展部分初步积极数据，Fasedienol用于社交焦虑障碍急性治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1172520288","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172520288?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:31","pubTimestamp":1778585475,"startTime":"0","endTime":"0","summary":"Vistagen公司宣布，在其Palisade-3三期研究中，关于Fasedienol用于社交焦虑障碍急性治疗的开放标签扩展部分，获得了初步的积极数据。这项研究目前仍在进行中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100851891","title":"VistaGen获FDA批准开展Refisolone新药临床研究，推进更年期血管舒缩症状（潮热）二期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1100851891","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100851891?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:35","pubTimestamp":1776861341,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics宣布，美国食品药品监督管理局（FDA）已就其Refisolone新药临床申请发出“研究可继续进行”许可函，这意味着公司可进一步开展针对更年期引发的血管舒缩症状（即潮热）的二期临床开发计划。\n此次监管绿灯为Refisolone的临床推进扫清了关键障碍，标志着该创新疗法在解决更年期女性潮热问题方面迈出实质性一步。公司计划基于这一许可加速推进二期临床试验，探索Refisolone在缓解更年期相关症状方面的潜力与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187789740","title":"VistaGen Therapeutics披露：被裁员工或获现金遣散费及临时医保","url":"https://stock-news.laohu8.com/highlight/detail?id=1187789740","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187789740?lang=zh_cn&edition=full","pubTime":"2026-03-11 19:07","pubTimestamp":1773227259,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，生物制药公司VistaGen Therapeutics, Inc. 正为其裁员计划中的受影响员工提供补偿方案。该方案可能包括一次性现金遣散费以及过渡期的医疗保险覆盖。\n这一举措反映了公司在业务调整过程中对员工权益的保障。通过提供经济补偿和延续医疗保障，VistaGen旨在减轻岗位变动对员工生活的短期冲击。SEC文件披露的细节表明，公司已就裁员补偿制定了具体实施框架。\n（注：根据公开信息，VistaGen Therapeutics为临床阶段生物制药企业，专注于开发新型神经科学疗法。此次人员调整或与公司战略重心优化相关。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592912681","title":"Vistagen Therapeutics, Inc.股价重挫78.99% 市值跌2857.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592912681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592912681?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:31","pubTimestamp":1765981882,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时31分，Vistagen Therapeutics, Inc.股票出现异动，股价急速下挫78.99%。截至发稿，该股报0.916美元/股，成交量885.289万股，换手率22.41%，振幅1.12%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Vyne Therapeutics Inc.、Aditxt, Inc.涨幅较大，Pmgc Holdings Inc.、Aditxt, Inc.、Vyne Therapeutics Inc.较为活跃，换手率分别为1009.00%、827.45%、236.84%，振幅较大的相关个股有Vyne Therapeutics Inc.、Mindwalk Holdings Corp.、Rezolute, Inc.，振幅分别为12.17%、11.31%、10.89%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217223122a6ae7069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217223122a6ae7069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","VTGN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1170517696","title":"VistaGen发布Palisade-3第三阶段公众演讲挑战研究的顶尖结果，Fasedienol用于急性社交焦虑症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1170517696","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170517696?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:33","pubTimestamp":1765978394,"startTime":"0","endTime":"0","summary":"VistaGen发布Palisade-3第三阶段公众演讲挑战研究的顶尖结果，Fasedienol用于急性社交焦虑症治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143674821","title":"VistaGen Therapeutics第三季度每股收益$(0.46)超出预期$(0.51)，销售额23.4万美元超出预期18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143674821","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143674821?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:44","pubTimestamp":1739483087,"startTime":"0","endTime":"0","summary":"与去年同期的每股亏损$相比，这是109.09%的下降。公司报告季度销售额为23.4万美元，超出分析师一致预期的18万美元，高出30%。与去年同期的41.14万美元相比，这一数据下降了43.12%。以上内容来自Benzinga Earnings专栏，原文如下：VistaGen $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 9.8 percent. This is a 109.09 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $234.00 thousand which beat the analyst consensus estimate of $180.00 thousand by 30.00 percent.  This is a ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"VistaGen Therapeutics第三季度每股收益$(0.46)超出预期$(0.51)，销售额23.4万美元超出预期18万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507467790","title":"Vistagen Therapeutics, Inc.盘中异动 大幅拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507467790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507467790?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:05","pubTimestamp":1738267529,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时05分，Vistagen Therapeutics, Inc.股票出现波动，股价大幅上涨5.59%。截至发稿，该股报3.02美元/股，成交量7.4433万股，换手率0.27%，振幅6.56%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1808.61%、328.29%、253.64%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为70.55%、65.98%、64.10%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310405299876d5ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310405299876d5ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTGN","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504816292","title":"Vistagen Therapeutics, Inc.盘中异动 股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504816292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504816292?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:32","pubTimestamp":1737124343,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时32分，Vistagen Therapeutics, Inc.股票出现波动，股价快速上涨6.16%。截至发稿，该股报3.10美元/股，成交量1.0667万股，换手率0.04%，振幅6.16%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Channel Therapeutics Corporation、Immuron Limited、Revance Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Bioline Rx Ltd较为活跃，换手率分别为92.11%、14.24%、6.82%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、天境生物、Jupiter Neurosciences, Inc.，振幅分别为25.26%、10.00%、9.84%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223223a225bc25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223223a225bc25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VTGN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2487256146","title":"Vistagen Therapeutics, Inc.盘中异动 早盘快速拉升5.20%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487256146","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487256146?lang=zh_cn&edition=full","pubTime":"2024-11-30 00:26","pubTimestamp":1732897566,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日00时26分，Vistagen Therapeutics, Inc.股票出现异动，股价大幅拉升5.20%。截至发稿，该股报2.83美元/股，成交量4.018万股，换手率0.14%，振幅5.76%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Passage Bio, Inc.涨幅较大，Silo Pharma, Inc.、Klotho Neurosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为176.47%、70.13%、62.72%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为130.29%、105.44%、68.75%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024113000260698e46ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024113000260698e46ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486036873","title":"Vistagen Therapeutics, Inc.盘中异动 早盘快速拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486036873?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:26","pubTimestamp":1732548389,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时26分，Vistagen Therapeutics, Inc.股票出现波动，股价急速上涨5.43%。截至发稿，该股报2.72美元/股，成交量5.9138万股，换手率0.21%，振幅4.65%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.08%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Exicure, Inc.涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为102.20%、99.15%、57.18%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Exicure, Inc.，振幅分别为71.29%、65.85%、49.39%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232629971a8688&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232629971a8688&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTGN","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484783510","title":"Vistagen Therapeutics, Inc.2024财年第三财季实现净利润-12.96百万美元，同比减少96.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484783510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484783510?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773008,"startTime":"0","endTime":"0","summary":"11月17日，Vistagen Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.96百万美元，同比减少96.66%；其中营业收入为183000.00美元，同比减少34.10%，每股基本收益为-0.42美元。从资产负债表来看，Vistagen Therapeutics, Inc.总负债9.52百万美元，其中短期债务525000.00美元，资产负债比为0.11，流动比率为13.30。机构评级：截至2024年11月17日，当前有3家机构对Vistagen Therapeutics, Inc.目标价做出预测，其中目标均价为13.00美元，其中最低目标价为12.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000441abc79103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000441abc79103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483630037","title":"Vistagen Therapeutics, Inc.盘中异动 快速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630037?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:20","pubTimestamp":1731435647,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时20分，Vistagen Therapeutics, Inc.股票出现异动，股价大幅跳水5.29%。截至发稿，该股报2.86美元/股，成交量10.7255万股，换手率0.40%，振幅5.30%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Genprex, Inc.、Kairos Pharma, Ltd.涨幅较大，Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为531.01%、426.42%、228.80%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为209.30%、105.45%、86.87%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111302204798e4227a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111302204798e4227a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2473484671","title":"Vistagen Therapeutics, Inc.盘中异动 下午盘急速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473484671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473484671?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:15","pubTimestamp":1728324911,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时15分，Vistagen Therapeutics, Inc.股票出现波动，股价大幅下挫5.32%。截至发稿，该股报2.85美元/股，成交量10.9968万股，换手率0.41%，振幅4.98%。Vistagen Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Oncolytics Biotech Inc.涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1628.95%、82.93%、60.41%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Akari Therapeutics Plc，振幅分别为107.82%、39.46%、37.93%。Vistagen Therapeutics, Inc.公司简介：VistaGen Therapeutics Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008021511ab68223a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008021511ab68223a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VTGN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vistagen.com","stockEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":0.0721},{"period":"3month","weight":0.0955},{"period":"6month","weight":-0.8598},{"period":"1year","weight":-0.7358},{"period":"ytd","weight":-0.0381}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vistagen Therapeutics, Inc.成立于1998年5月26日，是一家临床阶段的生物制药公司，致力于开发新一代治疗焦虑、抑郁和某些其他中枢神经系统(CNS)疾病的疗法，这些疾病目前的治疗方案不足，导致全球大型和不断增长的市场存在大量未满足的需求，产品线包括三种临床阶段的CNS候选产品，PH94B、PH10和AV-101，每种产品都具有不同的作用机制，迄今为止在所有临床研究中都具有卓越的安全性，并且在多种CNS适应症中具有治疗潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.126859},{"month":2,"riseRate":0.3,"avgChangeRate":-0.102734},{"month":3,"riseRate":0.2,"avgChangeRate":-0.108038},{"month":4,"riseRate":0.6,"avgChangeRate":0.018256},{"month":5,"riseRate":0.6,"avgChangeRate":0.004344},{"month":6,"riseRate":0.3,"avgChangeRate":-0.086533},{"month":7,"riseRate":0.3,"avgChangeRate":-0.026703},{"month":8,"riseRate":0.8,"avgChangeRate":0.268993},{"month":9,"riseRate":0.3,"avgChangeRate":0.032968},{"month":10,"riseRate":0.5,"avgChangeRate":-0.061688},{"month":11,"riseRate":0.4,"avgChangeRate":-0.060004},{"month":12,"riseRate":0.7,"avgChangeRate":0.164554}],"exchange":"NASDAQ","name":"VistaGen Therapeutics, Inc.","nameEN":"VistaGen Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VistaGen Therapeutics, Inc.(VTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VistaGen Therapeutics, Inc.(VTGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VistaGen Therapeutics, Inc.,VTGN,VistaGen Therapeutics, Inc.股票,VistaGen Therapeutics, Inc.股票老虎,VistaGen Therapeutics, Inc.股票老虎国际,VistaGen Therapeutics, Inc.行情,VistaGen Therapeutics, Inc.股票行情,VistaGen Therapeutics, Inc.股价,VistaGen Therapeutics, Inc.股市,VistaGen Therapeutics, Inc.股票价格,VistaGen Therapeutics, Inc.股票交易,VistaGen Therapeutics, Inc.股票购买,VistaGen Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VistaGen Therapeutics, Inc.(VTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VistaGen Therapeutics, Inc.(VTGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}